MiMedx Group Q2 2024 Adj. EPS $0.08, Inline, Sales $87.207M Miss $88.919M Estimate
Portfolio Pulse from Benzinga Newsdesk
MiMedx Group (NASDAQ:MDXG) reported Q2 2024 earnings per share of $0.08, meeting analyst expectations. However, the company's sales of $87.207 million missed the consensus estimate of $88.919 million by 1.93%, though it represents a 7.32% increase from the same period last year.
July 31, 2024 | 8:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MiMedx Group reported Q2 2024 earnings per share of $0.08, meeting analyst expectations. However, sales of $87.207 million missed the consensus estimate by 1.93%, despite a 7.32% year-over-year increase.
The earnings per share met expectations, which is neutral for the stock. However, the slight miss in sales estimates could be seen as a minor negative, though the year-over-year sales growth is a positive factor. Overall, the impact is likely neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100